Madrid to Invest 10.6 Million in 49,000 Doses to Immunize Babies Against RSV

The Community of Madrid will allocate funds to acquire antibodies to protect newborns and infants from respiratory syncytial virus, which causes bronchiolitis and pneumonia.

Generic image of a baby's hand holding an adult's finger, symbolizing protection.
IA

Generic image of a baby's hand holding an adult's finger, symbolizing protection.

The Governing Council of the Community of Madrid has approved an investment of 10.6 million euros to acquire 49,000 doses of antibodies aimed at protecting babies and infants from respiratory syncytial virus (RSV), responsible for bronchiolitis and pneumonia.

This free measure will be administered to newborns during the campaign starting next autumn, through a single injection in all maternity hospitals in the region. Infants under six months at the start of the campaign will receive this protection in other public hospitals of the Madrid Health Service.
The regional Executive was a pioneer in Spain in launching this immunization campaign three years ago, which has shown a very positive impact on public health, achieving a 90% reduction in RSV-related hospital admissions.

"This measure, designed by the General Directorate of Public Health, has been consolidated as a preventive action with excellent results, highly valued by Madrid residents."

a spokesperson for the Community of Madrid
During the last campaign, which ran from October 1, 2025, to last March 31, a global coverage of 90% of the target population was achieved, a similar percentage to that of the 2024/25 campaign.
This initiative complements the 12.5 million euros approved last March by the Governing Council for the second campaign of protection against the same virus in people over 80 years old, through the acquisition of 100,000 doses of vaccines. The Community of Madrid was also a pioneer in Spain with this measure last year, seeking to reduce cases of pneumonia and bronchiolitis, as well as hospital admissions and possible associated complications.